Titre:
  • Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
Auteur:Melsens, Karin; Vandecasteele, Els E.H.; Deschepper, Ellen; Badot, Valérie; Blockmans, Daniel; Brusselle, Guy; De Langhe, Ellen; De Pauw, Marleen; Debusschere, Claire; Decuman, Saskia; Deroo, Liselotte; Houssiau, Frédéric; Lenaerts, Jan J.L.; Piette, Yves; Thevissen, Kristof; Vanthuyne, Marie; Westhovens, René; Wijnant, Sara; De Keyser, Filip; Smith, Vanessa
Informations sur la publication:Acta Clinica Belgica (English ed. Printed), 73, 2, page (119-125)
Statut de publication:Publié, 2018-03
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:anti-CD20 therapy
clinical outcome
clinical trial
early severe diffuse scleroderma
rituximab
Systemic sclerosis
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1784-3286
info:doi/10.1080/17843286.2017.1372244
info:scp/85029445469